VIAject™
Sponsors
Biodel
Conditions
Diabetes MellitusType 1 Diabetes MellitusType 2 Diabetes Mellitus
Phase 3
An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus
CompletedNCT00542724
Start: 2006-09-30Updated: 2015-08-03
An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes Mellitus
CompletedNCT00542633
Start: 2006-12-31Updated: 2015-08-18
An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 2 Diabetes Mellitus
CompletedNCT00875108
Start: 2007-07-31End: 2010-01-31Updated: 2015-07-29
An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 1 Diabetes Mellitus
CompletedNCT00875459
Start: 2007-04-30End: 2010-02-28Updated: 2015-07-29